Optimal Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: An Umbrella Review.

[1]  J. Douketis,et al.  2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy. , 2017, The Canadian journal of cardiology.

[2]  S. Bangalore,et al.  Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. , 2017, The American journal of medicine.

[3]  A. Briasoulis,et al.  Long (>12 Months) and Short (<6 Months) Versus Standard Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Systematic Review and Meta-Analysis , 2017, American journal of therapeutics.

[4]  Wei Wang,et al.  The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials. , 2017, International journal of cardiology.

[5]  G. Condorelli,et al.  Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials , 2017, Circulation. Cardiovascular interventions.

[6]  G. Wells,et al.  Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review , 2017, BMJ Open.

[7]  G. Fu,et al.  Shorter- versus Longer-duration Dual Antiplatelet Therapy in Patients with Diabetes Mellitus Undergoing Drug-eluting Stents Implantation: A Meta-analysis of Randomized Controlled Trials , 2016, Chinese medical journal.

[8]  G. Stone,et al.  Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated With Second-Generation Drug-Eluting Stents. , 2016, The American journal of cardiology.

[9]  Xiufang Lin,et al.  Meta-analysis of randomized controlled trials on efficacy and safety of extended thienopyridine therapy after drug-eluting stent implantation. , 2016, Cardiovascular diagnosis and therapy.

[10]  H. Suryapranata,et al.  Optimal Duration of Dual Antiplatelet Therapy After DES Implantation , 2016, Angiology.

[11]  B. Cheung,et al.  Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of randomized controlled trials. , 2015, International journal of cardiology.

[12]  B. Cheung,et al.  Duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of large randomised controlled trials , 2015, Scientific Reports.

[13]  Giuseppe Biondi-Zoccai,et al.  Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials , 2015, The Lancet.

[14]  Biao Xu,et al.  Optimize the duration of DAPT following DES implantation: An updated system review and meta-analysis of 10 randomized trials , 2015 .

[15]  H. Schunkert,et al.  Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials , 2015, Clinical Research in Cardiology.

[16]  G. Lip,et al.  Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials , 2015, BMJ : British Medical Journal.

[17]  J. Wójcik,et al.  6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. , 2015, Journal of the American College of Cardiology.

[18]  Braunwald,et al.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. , 2014, The New England journal of medicine.

[19]  E. Vicaut,et al.  Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial , 2014, The Lancet.

[20]  M. Jeong,et al.  Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Randomized, Controlled Trial , 2014, Circulation.

[21]  T. Hu,et al.  AS-171 Duration Of Dual Antiplatelet Therapy And Outcomes After Left Main Percutaneous Coronary Intervention , 2012 .

[22]  J. Marchesini,et al.  Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial , 2012, Circulation.

[23]  M. Jeong,et al.  Duration of dual antiplatelet therapy after implantation of drug-eluting stents. , 2010, The New England journal of medicine.

[24]  P. Tugwell,et al.  Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.

[25]  C. Godfrey,et al.  Chapter 10: Umbrella Reviews , 2019, JBI Manual for Evidence Synthesis.

[26]  P. Kolh,et al.  2017 European Society of Cardiology (ESC) focused update on dual antiplatelet therapy in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.